<DOC>
	<DOCNO>NCT00790296</DOCNO>
	<brief_summary>The primary objective study evaluate thyrotropin release hormone ( TRH ) treatment cancer-related fatigue . The central hypothesis pilot study TRH efficacious placebo alleviate cancer-related fatigue patient breast prostate cancer .</brief_summary>
	<brief_title>Evaluation Synthetic Thyrotropin Releasing Hormone ( TRH ) Treatment Cancer-related Fatigue</brief_title>
	<detailed_description />
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Thyrotropin-Releasing Hormone</mesh_term>
	<mesh_term>Calcitonin</mesh_term>
	<criteria>Patients diagnosis cancer undergone currently undergo radiation chemotherapy therapy expect significant change cancer treatment session study period Provide write informed consent prior initiation studyrelated procedure . Male female , 18 year age old diagnosis cancer . Able understand comply requirement study . Exclusion criterion : Hospitalized patient . Patients identifiable diagnosis substance abuse dependence within 6 month prior evaluation ( except full remission , caffeine nicotine dependence ) define DSMIV criterion . Patients follow cardiovascular symptomatology . Office systolic BP &gt; 160mmHg and/or diastolic BP &gt; 90mmHg . Persons rest hear rate &gt; 100 beat per minute Persons history chronic stable angina Persons myocardial infarction unstable angina vascular surgery within 6 month Persons history vasovagal syncopal episodes Patients know clinically significant cardiac problem Patients history stroke significant risk stroke . Patients history seizures Patients history asthma Patients clinically significant unstable inadequately treat co morbid medical condition patient currently medication would confound evaluation CF ( e.g . diabetes , CHF , history cancer ) judge investigator . Patients clinically significant , unstable psychiatric disorder ( except mild moderate depressive anxiety disorder ) patient psychotropic medication would confound CF assessment judge investigator . Patients history depressive anxiety disorder exclude study Patients history illnesses treatment would expect significantly alter immune function ( viz . HIV infection , systemic lupus erythematosus , patient take immunosuppressive medication ) . Patients diseases medication significantly affect hypothalamicpituitaryadrenocortical ( HPA ) axis function ( viz . Cushings disease ) . Pregnant patient , breastfeed plan become pregnant study Patients know allergy TRH Any condition , , opinion investigator , would make patient , unsuited enrollment , confound CF evaluation could interfere patient 's participation study . Patients medically reversible cause CF ( viz. , anemia , hypothyroidism , electrolyte abnormality etc ) . Patients potentially treatable associate symptom dominate CF scenario pain , sleep disturbance may significant causal relationship CF . Patients identify pregnant base pregnancy test screening . Patients physically unable complete walk test ( WT ) assessment WT would increase risk medical complication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>cancer fatigue</keyword>
</DOC>